Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115


Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism.

Menzfeld C, John M, van Rossum D, Regen T, Scheffel J, Janova H, Götz A, Ribes S, Nau R, Borisch A, Boutin P, Neumann K, Bremes V, Wienands J, Reichardt HM, Lühder F, Tischner D, Waetzig V, Herdegen T, Teismann P, Greig I, Müller M, Pukrop T, Mildner A, Kettenmann H, Brück W, Prinz M, Rotshenker S, Weber MS, Hanisch UK.

Glia. 2015 Jun;63(6):1083-99. doi: 10.1002/glia.22803. Epub 2015 Mar 2.


Total arthroplasty of the hip by fritted alumina prosthesis. Experimental study and 1st clinical applications.

Boutin P.

Orthop Traumatol Surg Res. 2014 Feb;100(1):15-21. doi: 10.1016/j.otsr.2013.12.004. Epub 2014 Jan 20.


Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.

Rao SP, Sancho J, Campos-Rivera J, Boutin PM, Severy PB, Weeden T, Shankara S, Roberts BL, Kaplan JM.

PLoS One. 2012;7(6):e39416. doi: 10.1371/journal.pone.0039416. Epub 2012 Jun 25.


Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.

Bagley RG, Rouleau C, Weber W, Mehraein K, Smale R, Curiel M, Callahan M, Roy A, Boutin P, St Martin T, Nacht M, Teicher BA.

Microvasc Res. 2011 Nov;82(3):253-62. doi: 10.1016/j.mvr.2011.09.004. Epub 2011 Sep 17.


Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models.

Siders WM, Shields J, Garron C, Hu Y, Boutin P, Shankara S, Weber W, Roberts B, Kaplan JM.

Leuk Lymphoma. 2010 Jul;51(7):1293-304. doi: 10.3109/10428191003777963.


Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.

Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA.

Microvasc Res. 2008 Nov;76(3):180-8. doi: 10.1016/j.mvr.2008.07.008. Epub 2008 Aug 8.


Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.

Bagley RG, Rouleau C, St Martin T, Boutin P, Weber W, Ruzek M, Honma N, Nacht M, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA.

Mol Cancer Ther. 2008 Aug;7(8):2536-46. doi: 10.1158/1535-7163.MCT-08-0050.


Common nonsynonymous variants in PCSK1 confer risk of obesity.

Benzinou M, Creemers JW, Choquet H, Lobbens S, Dina C, Durand E, Guerardel A, Boutin P, Jouret B, Heude B, Balkau B, Tichet J, Marre M, Potoczna N, Horber F, Le Stunff C, Czernichow S, Sandbaek A, Lauritzen T, Borch-Johnsen K, Andersen G, Kiess W, Körner A, Kovacs P, Jacobson P, Carlsson LM, Walley AJ, Jørgensen T, Hansen T, Pedersen O, Meyre D, Froguel P.

Nat Genet. 2008 Aug;40(8):943-5. doi: 10.1038/ng.177. Epub 2008 Jul 6.


Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families.

Maziade M, Rouleau N, Gingras N, Boutin P, Paradis ME, Jomphe V, Boutin J, Létourneau K, Gilbert E, Lefebvre AA, Doré MC, Marino C, Battaglia M, Mérette C, Roy MA.

Schizophr Bull. 2009 Sep;35(5):919-30. doi: 10.1093/schbul/sbn058. Epub 2008 Jun 11.


The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.

Rouleau C, Menon K, Boutin P, Guyre C, Yoshida H, Kataoka S, Perricone M, Shankara S, Frankel AE, Duesbery NS, Vande Woude G, Biemann HP, Teicher BA.

Int J Oncol. 2008 Apr;32(4):739-48.


Evaluating the association of FAAH common gene variation with childhood, adult severe obesity and type 2 diabetes in the French population.

Durand E, Lecoeur C, Delplanque J, Benzinou M, Degraeve F, Boutin P, Marre M, Balkau B, Charpentier G, Froguel P, Meyre D.

Obes Facts. 2008;1(6):305-9. doi: 10.1159/000178157. Epub 2008 Dec 12.


A genome-wide association study identifies novel risk loci for type 2 diabetes.

Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P.

Nature. 2007 Feb 22;445(7130):881-5. Epub 2007 Feb 11.


Genotype-by-nutrient interactions assessed in European obese women. A case-only study.

Santos JL, Boutin P, Verdich C, Holst C, Larsen LH, Toubro S, Dina C, Saris WH, Blaak EE, Hoffstedt J, Taylor MA, Polak J, Clement K, Langin D, Astrup A, Froguel P, Pedersen O, Sorensen TI, Martinez JA; NUGENOB* consortium.

Eur J Nutr. 2006 Dec;45(8):454-62. Epub 2006 Nov 1.


Distinct impaired regulation of SOCS3 and long and short isoforms of the leptin receptor in visceral and subcutaneous fat of lean and obese women.

Séron K, Corset L, Vasseur F, Boutin P, Gómez-Ambrosi J, Salvador J, Frühbeck G, Froguel P.

Biochem Biophys Res Commun. 2006 Oct 6;348(4):1232-8. Epub 2006 Jul 24.


Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets.

Sørensen TI, Boutin P, Taylor MA, Larsen LH, Verdich C, Petersen L, Holst C, Echwald SM, Dina C, Toubro S, Petersen M, Polak J, Clément K, Martínez JA, Langin D, Oppert JM, Stich V, Macdonald I, Arner P, Saris WH, Pedersen O, Astrup A, Froguel P; NUGENOB Consortium.

PLoS Clin Trials. 2006 Jun;1(2):e12. Epub 2006 Jun 30.


The INS VNTR locus does not associate with smallness for gestational age (SGA) but interacts with SGA to increase insulin resistance in young adults.

Vu-Hong TA, Durand E, Deghmoun S, Boutin P, Meyre D, Chevenne D, Czernichow P, Froguel P, Levy-Marchal C.

J Clin Endocrinol Metab. 2006 Jun;91(6):2437-40. Epub 2006 Apr 4.


Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population.

Vaxillaire M, Dechaume A, Vasseur-Delannoy V, Lahmidi S, Vatin V, Leprêtre F, Boutin P, Hercberg S, Charpentier G, Dina C, Froguel P.

Diabetes. 2006 Mar;55(3):856-61.


Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.

Rouleau C, Roy A, St Martin T, Dufault MR, Boutin P, Liu D, Zhang M, Puorro-Radzwill K, Rulli L, Reczek D, Bagley R, Byrne A, Weber W, Roberts B, Klinger K, Brondyk W, Nacht M, Madden S, Burrier R, Shankara S, Teicher BA.

Mol Cancer Ther. 2006 Feb;5(2):219-29.


Obesity susceptibility CART gene polymorphism contributes to bone remodeling in postmenopausal women.

Guérardel A, Tankó LB, Boutin P, Christiansen C, Froguel P.

Osteoporos Int. 2006 Jan;17(1):156-7. No abstract available.


Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.

Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin V, Ghoussaini M, Wachter C, Hercberg S, Charpentier G, Patsch W, Pattou F, Charles MA, Tounian P, Clément K, Jouret B, Weill J, Maddux BA, Goldfine ID, Walley A, Boutin P, Dina C, Froguel P.

Nat Genet. 2005 Aug;37(8):863-7. Epub 2005 Jul 17.


GAD2: a polygenic contribution to genetic susceptibility for common obesity?

Boutin P, Froguel P.

Pathol Biol (Paris). 2005 Jul;53(6):305-7. No abstract available.


Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity.

Vasseur F, Helbecque N, Lobbens S, Vasseur-Delannoy V, Dina C, Clément K, Boutin P, Kadowaki T, Scherer PE, Froguel P.

Diabetologia. 2005 May;48(5):892-9. Epub 2005 Apr 14.


Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population.

Guérardel A, Barat-Houari M, Vasseur F, Dina C, Vatin V, Clément K, Eberlé D, Vasseur-Delannoy V, Bell CG, Galan P, Hercberg S, Helbecque N, Potoczna N, Horber FF, Boutin P, Froguel P.

BMC Genet. 2005 Apr 11;6:19.


Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children?

Meyre D, Boutin P, Tounian A, Deweirder M, Aout M, Jouret B, Heude B, Weill J, Tauber M, Tounian P, Froguel P.

J Clin Endocrinol Metab. 2005 Apr;90(4):2384-90. Epub 2005 Jan 25.


Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R.

Nanda A, Buckhaults P, Seaman S, Agrawal N, Boutin P, Shankara S, Nacht M, Teicher B, Stampfl J, Singh S, Vogelstein B, Kinzler KW, St Croix B.

Cancer Res. 2004 Dec 1;64(23):8507-11.


Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians.

Durand E, Boutin P, Meyre D, Charles MA, Clement K, Dina C, Froguel P.

Diabetes. 2004 Sep;53(9):2483-6. Erratum in: Diabetes. 2005 Feb;54(2):587.


GAD2 on chromosome 10p12 is a candidate gene for human obesity.

Boutin P, Dina C, Vasseur F, Dubois S, Corset L, Séron K, Bekris L, Cabellon J, Neve B, Vasseur-Delannoy V, Chikri M, Charles MA, Clement K, Lernmark A, Froguel P.

PLoS Biol. 2003 Dec;1(3):E68. Epub 2003 Nov 3.


[Results of fine needle aspiration biopsy, frozen section diagnosis and definite histological results in thyroid pathology. Report of 163 cases].

Boutin P, Bozorg Grayeli A, Terrada C, Rondini-Gilli E, Mosnier I, Julien N, Bouccara D, Groussard O, Bok B, Sterkers O.

Rev Laryngol Otol Rhinol (Bord). 2003;124(1):59-63. French.


Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease.

Helbecque N, Abderrahamani A, Meylan L, Riederer B, Mooser V, Miklossy J, Delplanque J, Boutin P, Nicod P, Haefliger JA, Cottel D, Amouyel P, Froguel P, Waeber G.

Mol Psychiatry. 2003 Apr;8(4):413-22, 363. Erratum in: Mol Psychiatry. 2003 Nov;8(11):947. Abderrhamani A [corrected to Abderrahamani A].


Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians.

Veiga-da-Cunha M, Delplanque J, Gillain A, Bonthron DT, Boutin P, Van Schaftingen E, Froguel P.

Diabetologia. 2003 May;46(5):704-11. Epub 2003 May 9.


Total esophagoplasty using a doubly vascularized free jejunal transplant: a last resort in two patients.

Germain MA, Hartl DM, Boutin P, Marandas P, Luboinski B.

Plast Reconstr Surg. 2003 Feb;111(2):801-4. No abstract available.


[Middle ear adenoma: report of two cases and review of the literature].

da Luz Martins M, Boutin P, Bozorg-Grayeli A, Cazals-Hatem D, Bouccara D, Sterkers O.

Ann Otolaryngol Chir Cervicofac. 2002 Dec;119(6):337-40. Review. French.


[Otosclerosis surgical techniques and results in 150 patients].

Rondini-Gilli E, Bozorg Grayeli A, Boutin P, Tormin Borges Crosara PF, Mosnier I, Bouccara D, Cyna-Gorse F, Rufat P, Sterkers O.

Ann Otolaryngol Chir Cervicofac. 2002 Sep;119(4):227-33. French.


Genetics of obesity.

Clement K, Boutin P, Froguel P.

Am J Pharmacogenomics. 2002;2(3):177-87. Review.


Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.

Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Leprêtre F, Dupont S, Hara K, Clément K, Bihain B, Kadowaki T, Froguel P.

Hum Mol Genet. 2002 Oct 1;11(21):2607-14.


Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients.

Housseau F, Lindsey KR, Oberholtzer SD, Gonzales MI, Boutin P, Moorthy AK, Shankara S, Roberts BL, Topalian SL.

J Immunol Methods. 2002 Aug 1;266(1-2):87-103.


No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasians.

Lacquemant C, Chikri M, Boutin P, Samson C, Froguel P.

Diabetologia. 2002 Apr;45(4):602-3; author reply 604. No abstract available.


Rapid SNP allele frequency determination in genomic DNA pools by pyrosequencing.

Neve B, Froguel P, Corset L, Vaillant E, Vatin V, Boutin P.

Biotechniques. 2002 May;32(5):1138-42.


Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1alpha in Africans with diabetes.

Collet C, Ducorps M, Mayaudon H, Dupuy O, Ceppa F, Boutin P, Froguel P, Bauduceau B.

Diabetes Metab. 2002 Feb;28(1):39-44.


Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p.

Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, Tobe K, Boutin P, Kadowaki T, Froguel P.

Diabetes. 2002 Apr;51(4):1247-55.


Mutation screening of the urocortin gene: identification of new single nucleotide polymorphisms and association studies with obesity in French Caucasians.

Delplanque J, Vasseur F, Durand E, Abderrahmani A, Dina C, Waeber G, Guy-Grand B, Clement K, Weill J, Boutin P, Froguel P.

J Clin Endocrinol Metab. 2002 Feb;87(2):867-9.


Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.

Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T.

Diabetes. 2002 Feb;51(2):536-40. Erratum in: Diabetes 2002 Apr;51(4):1294.


Alumina-on-alumina total hip arthroplasty: a minimum 18.5-year follow-up study.

Hamadouche M, Boutin P, Daussange J, Bolander ME, Sedel L.

J Bone Joint Surg Am. 2002 Jan;84(1):69-77.


Genetics of pathways regulating body weight in the development of obesity in humans.

Froguel P, Boutin P.

Exp Biol Med (Maywood). 2001 Dec;226(11):991-6. Review.


Genetics of human obesity.

Boutin P, Froguel P.

Best Pract Res Clin Endocrinol Metab. 2001 Sep;15(3):391-404. Review.


Linkage and association studies between the proopiomelanocortin (POMC) gene and obesity in caucasian families.

Delplanque J, Barat-Houari M, Dina C, Gallina P, Clément K, Guy-Grand B, Vasseur F, Boutin P, Froguel P.

Diabetologia. 2000 Dec;43(12):1554-7.


Total hip arthroplasty using a ceramic prosthesis. Pierre Boutin (1924-1989).

Boutin P.

Clin Orthop Relat Res. 2000 Oct;(379):3-11. No abstract available.


Use of and attitudes about alternative and complementary therapies among outpatients and physicians at a municipal hospital.

Boutin PD, Buchwald D, Robinson L, Collier AC.

J Altern Complement Med. 2000 Aug;6(4):335-43.


A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals.

Marra CM, Boutin P, McArthur JC, Hurwitz S, Simpson PA, Haslett JA, van der Horst C, Nevin T, Hook EW 3rd.

Clin Infect Dis. 2000 Mar;30(3):540-4.


Supplemental Content

Loading ...
Support Center